| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
1 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
| mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |